Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.
Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials.
Smit JM, Van Der Zee PA, Stoof SCM, Van Genderen ME, Snijders D, Boersma WG, Confalonieri P, Salton F, Confalonieri M, Shih MC, Meduri GU, Dequin PF, Le Gouge A, Lloyd M, Karunajeewa H, Bartminski G, Fernández-Serrano S, Suárez-Cuartín G, van Klaveren D, Briel M, Schönenberger CM, Steyerberg EW, Gommers DAMPJ, Bax HI, Bos WJW, van de Garde EMW, Wittermans E, Grutters JC, Blum CA, Christ-Crain M, Torres A, Motos A, Reinders MJT, Van Bommel J, Krijthe JH, Endeman H.